Oceania Healthcare Limited logo

Oceania Healthcare doubles profit for half year

Half Year Results24 January 2018OCAHealthcare

MEDIA RELEASE
25 January 2018

Oceania Healthcare doubles profit for the six months

ended 30 November 2017

Highlights

• Reported net profit after tax increased by $20.5m (93%) compared with the prior

corresponding period (pcp) to $42.5m due to strong uplift in valuation of investment

properties, higher resale margins and sale of new retirement village units.

• Underlying net profit after tax improved by $10.9m (121%) compared with pcp to

$19.9m.

• Operating cashflow improved from $12.8m to $17.1m (34%) due to the increase in

profit and reduction in interest paid compared with pcp.

• Total assets increased by $160m from pcp to $1.0bn due to significant development

capital expenditure, acquisitions and revaluations. New greenfields site acquisition in

St Heliers, Auckland announced.

• Development programme continuing to accelerate with 360 units and care suites

under construction across four sites.

• Key stage of Meadowbank Village (Auckland) development practically complete, with

Care facility certified. Presale applications received on 26 apartments out of a total of

62 in this stage.

• Supreme Winner Overall Excellence in Care Award for the third consecutive year for

innovative “I Love Music” programme.

• Interim dividend per share announced of 2.1 cents per share (not imputed) payable

on 20 February 2018.

$m’s

Six months to 30

November

Growth


2017 2016 $m %

Operating

Revenue

92.1 89.2 2.9 3.3%

Reported

NPAT

42.5 22.0 20.5 93.2%

Underlying

NPAT

19.9 9.0 10.9 121.1%

Total Assets 999.1 838.6 160.5 19.1%

Operating

Cashflow

17.1 12.8 4.3 33.6%



Earl Gasparich, Chief Executive Officer, commented:

We have delivered a strong result for the first half of the year and expect to achieve our

forecasts for the year ending 31 May 2018 set out in our Product Disclosure Statement.

Our Retirement Village business grew $4.2m or 35% in the period due to the sales of new

units at our Lady Allum Village (Milford, Auckland) that were completed in April last year, as

well as an increase in our resale margins to 28% (3% over last year). Earnings generated

from our Care business declined by $2.0m (11%) due to both the decommissioning of sites

for redevelopment purposes and softer occupancy in some DHB regions, the impact of which

was partially offset by good cost control.

All of the development projects outlined in the Product Disclosure Statement are well on

track. Completed developments - Elmwood (Manurewa, Auckland) and Stoke (Nelson) -

have been delivered on time and on Forecast. The third stage of our Meadowbank Village

(Auckland), a significant component of the FY18 Forecast, is practically complete with the

Care facility now open and 26 out of the 62 new apartments are subject to presale

application, which is already almost the levels of sales forecast for the full year.

In the second half of the year we will continue to sell down the Lady Allum Village Attwood

apartments (Milford, Auckland) with 30 of the 44 apartments completed in April 2017 already

sold or under application, Elmwood (Manurewa, Auckland), Stoke (Nelson) and

Meadowbank (Auckland) Stage 3. We will commence presales of “The Sands” (formerly

Maureen Plowman) on the beachfront of Browns Bay (North Shore of Auckland) for which we

already have received extraordinarily high levels of inquiry. We have also just commenced

the redevelopment of our Trevellyn facility in Hamilton with the first stage comprising a new

90-bed Care Suite facility as well as detailed design and consenting for our newly acquired

site in Waimarie Street, St Heliers (Auckland).

In our Care business, we will roll out our Clinical Information System which enhances the

way we organise the delivery of care to our residents and streamlines our compliance

requirements, and continue the roll out of our Award winning “I Love Music” programme.

On behalf of the Board, Oceania Chair Liz Coutts confirmed that an interim dividend of 2.1

cents per share (not imputed) would be paid to shareholders on 20 February 2018. This

dividend reflects Oceania’s steady earnings and cash flow and is in line with the Board

policy.


ENDS


Oceania Healthcare Limited is New Zealand’s third largest residential aged care provider and sixth largest

retirement village operator. Oceania Healthcare has a total of 3,893 beds, suites and units located at 50 sites in

the North and South Islands.



Appendix – reconciliation of reported net profit after tax to underlying net profit after tax



$m

Reported net profit after tax 42.5

Less: Change in fair value of investment property and

reversal of impairment of property, plant and

equipment

(35.3)

Add: Realised gain on resale 6.7

Add: Realised development margin 4.1

Add: Deferred tax expense/(benefit) 1.9

Underlying net profit after tax 19.9

---

Results
Presentation

25 January 2018

for the Six Months Ended 30 November 2017

11
01Highlights of the six months ended 30 November 20172

02Business Overview and Strategy7

03Update on Developments13

04Financial Results19

05Appendices33

SECTIONPAGE

Agenda

2
STRICTLY CONFIDENTIAL

Highlights of the six months ended 30 November 2017

SECTION 1

1

3
Reported NPAT and Pro forma Underlying

1

EBITDA ahead of the previous

corresponding period

1. Underlying NPAT is a non-GAAP measure used by Oceania to monitor business performance and is a consideration in determining dividend

distributions. Refer to page 41 in the Appendices for a definition of Underlying NPAT. Underlying NPAT is reported in the operating segment note of

Oceania's audited consolidated financial statements. The pro forma adjustments are reconciled on page 21 of this presentation. Refer to page 42

in the Appendices for an explanation of the pro forma adjustments made.

We have delivered a strong interim financial result as well as continuing to execute our key developments and

operational initiatives. We expect to achieve our IPO Forecasts for the year ending 31 May 2018

1HY2018 Highlights

1

●Underlying NPAT of $19.9m, increased 121% from $9.0m in the previous corresponding period (“pcp”)

●Reported NPAT of $42.5m, increased 93% from $22.0m in the pcp

●Pro Forma Underlying EBITDA of $25.3m, increased 9% from $23.3m in the pcp

●Operating cashflow of $17.1m, increased 34% from $12.8m in the pcp

●Total assets increased by $160.5m from 1HY2017 to reach approximately $1.0bn

Developments on track

2

●25 units completed at Elmwood in November 2017 (on time and on forecast cost)

●30 care suites completed and MoHcertified, and 62 apartments due for completion in January 2018, at

Meadowbank(on time and forecast cost)

●10 units completed at Stoke in December 2017 (on time and on forecast cost)

●360 units and care suites are under construction at The Sands (formerly Maureen Plowman), Melrose,

Meadowbankand Trevellyn

●New greenfield acquisition in the prime Auckland suburb of St Heliers

4
Operational Excellence

We have delivered a strong interim financial result as well as continuing to execute our key developments and

operational initiatives. We expect to achieve our IPO Forecasts for the year ending 31 May 2018

1HY2018 Highlights (continued)

3

●Supreme Winner Overall Excellence in Care Award for the third consecutive year for innovative “I Love

Music” programme

●Continued our strong MoHaudit results with 25% of facilities at 4 years, all others at 3 years (up from 20% at

4 years as at May-17)

●Commenced the implementation of a new clinical information system

●Continuation of the conversion of care beds (7) and serviced apartments (39) to care suites

Interim dividend declared

4

●Maiden Interim dividend per share announced of 2.10 cents per share (not imputed

1

), in line with IPO

forecasts

●Record date of 13 February 2018. Payment date of 20 February 2018

●Annual target dividend payoutof 50-60% of Underlying NPAT

1. The dividends are not imputed due to the availability of existing tax losses.

5
Reported NPAT and Pro Forma Underlying EBITDA are ahead of the pcp. Total assets as at 1HY2018 approximately $1.0b

1HY2018 Financial highlights

Reported NPAT

Total AssetsOperating Cash Flow

Pro forma Underlying EBITDA

0.7

0.8

0.8

0.9

1.0

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1HY20162HY20161HY20172HY20171HY2018

NZD $B's

19.4

20.2

12.8

26.1

17.1

0.0

5.0

10.0

15.0

20.0

25.0

30.0

1HY20162HY20161HY20172HY20171HY2018

NZD $M's

23.6

23.4

23.3

21.7

25.3

0.0

5.0

10.0

15.0

20.0

25.0

30.0

1HY20162HY20161HY20172HY20171HY2018

NZD $M’s

27.1

21.6

22.0

22.9

42.5

0.0

10.0

20.0

30.0

40.0

50.0

1HY20162HY20161HY20172HY20171HY2018

NZD $M's

6
lWinner of the New Zealand Aged Care Association

overall excellence in care award (third year in a row)

lContinued our excellent MoHaudit results with 25% of

facilities at 4 years, all others at 3 years (up from 20% at

4 years as at May-17)

lAfter a successful trial at our Lady Allumsite in Milford,

we are rolling out the Oceania “I Love Music”

programme across all our sites

lImplementation of our new clinical information system

has commenced

lWinner of the Senior Lifestyle Cuisine Award (third year

in a row)

lContinuation of conversions of care beds to care suites,

with 9 care beds converted to 7 care suites at

Woodlands and Addington Lifestyle and 39 serviced

apartments converted to care suites at Elmwood and

Heretaunga

lLaunched new moving and handling training

programme across all facilities to reduce injury rates

when transferring residents

Enhancing our clinical care platform, receiving industry recognition and strong MoH certification results

Operational highlights

2015, 2016 & 2017

7
STRICTLY CONFIDENTIAL

Business Overview and Strategy

SECTION 2

2

8
Care

Beds

Care

SuitesUnitsTotal

North Island1,976170741

2,887

South Island593118295

1,006

Total Existing

1

2,5692881,0363,893

DevelopmentPipeline

3

06651,117

1,782

Less decommissions(311)0(78)

(389)

Net DevelopmentPipeline

2

(311)6651,0391,393

Total post development

2,2589532,0755,286

1. Comprising 48 operating facilities and 3 undeveloped sites. Facility numbers as at 30 November 2017. 2. Current and planned developments. 3. Includes 378Care Studios which may be initially sold with a PAC, and may subsequently be

sold under an ORA. Meadowbankstage 3 (30 care suites and 62 units) and Stoke (10 units) are included in the development pipeline. These were substantially complete as at 30 Nov 2017 4. Future composition assumes execution of current

planned development of Oceania’s Brownfield Development landbank. Refer to Appendices for movements in the portfolio from 31 May 2017.

Current and future portfolio composition

4

–Remaining “needs” focused

Current and future portfolio composition

4

–Remaining “needs”

focused

We are a large national operator with a portfolio of 51 sites

Oceania at a glance

Hawke’s Bay

Auckland

Hamilton

Tauranga

Wellington

Nelson

Christchurch

Locations with

Development Land Bank

Locations with No

Development Land Bank

Oceania’s site locations

66%

43%

7%

18%

27%

39%

Current CompositionPost Development Composition

Care BedsCare SuitesUnits

9
Our business model supports a combination of dividend yield with long term growth potential

Summary of Oceania’s investment proposition

Aged care

Village

Development

Stable revenue from “needs-based”

care service and government funding....

Regular DMF earnings stream....

...with growth through premium

charging and care suite model

...and resale margins from existing

embedded value

Developments drive future DMF and

care earnings streams...

...as well as upfront development

cashflow

10
Source: Results presentations of other operators

Comparison to other listed operators

Our focus is aged care with a growing retirement village business

Oceania’s strategic positioning

Future portfolio compositionExisting portfolio composition

7%

20%

35%

50%

66%

0.3%

7%

11%

12%

19%

19%

82%

68%

45%

30%

27%

Metlifecare

Summerset

Ryman

Arvida

Oceania

Care BedsCare SuitesServiced UnitsIndependent Units

11%

17%

33%

39%

43%

4%

18%

8%

16%

19%

15%

81%

67%

48%

42%

39%

11
1. Statistics New Zealand population forecasts as at March 2017. 2. Average annual growth of 0.8% from 2013 –2016.

The care suite model is integral to us meeting the needs of customers

Estimated population growth

1

489,800

227,800

-

100,000

200,000

300,000

400,000

500,000

600,000

700,000

800,000

1995200020052010201520192024202920342039

Population

Aged 75 to 84

Population

Aged 85+

Care Strategy

●Continuing growth and ageing of the New

Zealand population is expected to significantly

increase demand for aged careover the next 20

years

●Due to the level of returns for operators achieved

under the traditional funding model, there has

been a low level of net aged Care Bed

additions

2

●Industry-led changes to the funding model have

been supported, primarily involving increased

private charging for aged care services

●Oceania has responded by developing the care

suite product (applying the ORA model over

care beds) and increasing PACs

Benefits of the care suite model

Ability to recycle capital, improving returns

for the development of aged care beds

Regular DMF earnings stream increases

earnings per bed

We have a clear growth strategy in aged care

12
Trevellyn–Hamilton

We are transforming our care offering as we execute our brownfields development pipeline. The current

projects under construction will double our number of care suites over the next two years

Developing new care facilities

1.

This includes 81 at Melrose, 90 at Trevellyn, 44 at The Sands and 62 at Meadowbank(including the 30 that were completed after 30 November 2017).

10%

Standard Beds

As at 30

Nov 17

New care suites

under

construction

Near term

Fully built

-

out pipeline

Decommissioned

care beds

Decommissioned

care beds

New care suites

in pipeline

20%

30%

Melrose –Tauranga

Care Suites/Studios

•We currently have 288 care suites in the portfolio which represents 10% of our total care beds

•We currently have 277 care suites under construction at Melrose, Trevellyn, The Sands (formerly Maureen Plowman) and Meadowbank

1

.

This will almost double the amount of care suites and lift this to 20% of our total beds

•Once the existing brownfields pipeline is fully built-out we will have 953 care suites in the portfolio(30% of our total care offering)

13
STRICTLY CONFIDENTIAL

Developments

SECTION 3

33

14
Meadowbank –Completed January 2018 (30 care suites, 62 apartments)

We will deliver our key developments during the IPO Forecast period on time and on forecast cost

Clear development pipeline

l25 Villas completed at Elmwood in November 2017. 10 villas completed at Stoke in

December 2017

l30 care suites at Meadowbank are complete with MOH certification with the 62 apartments

practically complete. CPU received and first residents moving in during February

lStage 4 at Meadowbank commenced in October 2017 (32 care suites, 49 apartments)

lThe Sands (formerly Maureen Plowman) is “out of the ground”. On track for completion in

FY2019

lMelrose development (81 care suites) commenced in July 17

lTrevellyn (90 care Suites) commenced in January 2018

lResource consent issued for Windermere in August 2017

lWaimarie Street, in St Heliers, Auckland, land under contract (66 units and care suites

planned)

lView Road (adjoining Eden Village) under contract (30 units planned)

Key changes since May-17

Elmwood –Completed October 2017 (25 villas)

Stoke –Completed December 2017 (10 villas)

15
We have a pipeline of 1,782 units. Of this 1,057 units, or 59%, is either under construction or consented

Clear development pipeline

Stage 2-3Christchurch Consented 53

Stage 1 Tauranga Under Construction 81

Windermere

Stage 1Christchurch Consented 75

WharerangiTaupo Under Construction 4

Stage 2-3Hamilton Consented 133

Stage 1Hamilton Under Construction 90

Trevellyn

Stage 2 -5Tauranga Consented 216

Green Gables Nelson Consented 88

Melrose

Construction period

Stage 4Auckland Under Construction 81

Meadowbank

Stage 3Auckland Substantially Complete 92

Stage 5Auckland Consented 26

The Sands Auckland Under Construction 108

Stoke Nelson Complete 10

Total Consented or Under Construction1057

Gross

Residences

LocationStatus

May 17 Nov 17May 18Nov 18Future

Facility

16
The care facility has been certified and 26 of the 62 apartments are under pre sale application

MeadowbankStage 3 practically complete

Stage 3 practically complete delivering

●30 care suites and studios (completed and

certified), and

●62 apartments (to be completed January 2018).

Certificate for public use received.

Stage 4 under construction with a further:

●32 care suites and studios, and

●49 apartments

26 apartments under presales application as of the

23 of January 2018 in line with the IPO Forecast

pricing. The IPO Forecast was 28 sales for the full

year to 31 May 2018

Meadowbank

Auckland

17
Construction of The Sands (formerly Maureen Plowman) is “out of the ground” with strong levels of presales interest

The Sands progressing on programme

●The Sands (formerly Maureen Plowman) in Browns

Bay, Auckland will provide 64 apartments and 44

care suites

●In-ground works were completed in November

2017 with the first floor slab to be poured in

January 2018

●Due for completion around May 2019

●Strong in-bound inquiry from potential purchasers

with presales to commence in March 2018

The Sands

Browns Bay, Auckland

18
In December 2017 we entered into a contract for the purchase of a 8,945m

2

site in the premium suburb of St Heliers, Auckland

Addition of premium site to our pipeline

Greenfield site under contract in the Auckland

suburb of St Heliers

●8,945m

2

with extensive harbour views

●Premium boutique aged care facility and

retirement village planned

●Strong forecast demand in the catchment area

●Median house price of $1.7m in the area

●66 units and care suites added to development

pipeline

WaimarieSt

St Heliers, Auckland

1919
01Income statement and segmental performance

02Balance sheet and drivers of Investment Property valuation

03Cashflow statement and analysis of operating cashflow

04Capital structure

Financial Results

4

20
Reported net profit after tax of $42.5m was $20.5m (93%) above the pcpresult and above the full year FY2017 result

Income statement

1. Note, as disclosed in the FY2017 annual financial statements the 1HY2017 income statement has been restated for an adjustmentto the deferred tax expense of $4.3m. All other income statement items

before tax are unchanged. There is no impact on cashflowor non-GAAP Underlying Profit.

l$92.1m operating revenue -includes care revenue

($79.9m), village weekly fees ($2.7m) and village

deferred management fees ($7.8m), and reflects

the equal pay settlement for health care assistants

that came into effect in July 2017

lFair value movement in IP and PPE driven by:

lRevaluation of existing village assets ($7.3m);

lUplift from new Meadowbank apartments

($11.7m)

lUplift from new Elmwood villas ($9.8m)

lUplift from sales of Lady Allum apartments

($5.2m)

lExisting care assets and development land not

revalued for these interim accounts

l1HY2018 operating expenses reflect the equal pay

settlement for health care assistants

Commentary Summary of Income Statement for the six months ended 30 November

NZDm1HY20181HY2017

1

FY2017

Operating revenue92.189.2174.8

Change in fair value of investment property34.132.657.2

Total Income126.3121.9232.0

Operating expenses (77.5)(73.0)(146.9)

Impairment of goodwill and loss on disposal of chattels0.00.0(1.0)

Impairment of property, plant and equipment1.1(3.2)(4.3)

Total Expenses(76.3)(76.2)(152.2)

Operating Profit

49.945.779.8

Transaction expenses0.0(0.9)(4.4)

Finance costs(1.4)(10.1)(20.1)

Depreciation and amortisation(4.1)(3.8)(7.9)

Profit before Income tax44.430.947.4

Taxation benefit/(expense)(1.9)(9.0)(2.5)

Reported Net Profit after Tax42.522.044.9

21
Underlying NPAT was $10.9m ahead of the pcpdue to increased development margins and the post IPO capital structure

Underlying earnings

1. See Appendices for a summary of pro forma adjustments.

lPro forma underlying EBITDA was $2.0m above

the pcp

lReduction in care segment driven by lower

occupancy and decommissioning of

development sites. Earnings per occupied bed

in line with the pcp

lResales margin above 1HY2017 with average

resale gain up to $96.6k per unit/suite, 25.0%

above the pcp average of $77.5k

lDevelopment margin of $4.1m underpinned

by sales of new Lady Allum apartments and

Elmwood villas

Commentary

Reconciliation of Underlying Adjustments

By segment

1HY20181HY2017FY2017

Aged Care16.418.431.9

Retirement Village16.312.126.8

Other/Corporate(7.4)(7.2)(13.7)

Pro forma Underlying

EBITDA

25.323.345.0

NZDm1HY20181HY2017FY2017

Reported Net profit after tax42.522.044.9

less: Change in fair value of investment property and PP&E(35.3)(29.5)(52.8)

add: Impairment of goodwill0.00.20.5

add: Loss on disposal of chattels at decommissioned sites0.00.00.5

add: Realised gains on resales6.76.412.7

add: Realised development margin4.10.95.2

Add: Deferred tax1.99.02.5

Underlying NPAT19.99.013.4

Pro forma adjustments:

Non-recurring or infrequent items

Transaction and Offer costs0.00.94.4

Structural changes

Listed company costs0.0(0.4)(0.7)

Listed capital structure0.08.517.0

Pro forma Underlying NPAT19.918.034.0

add: Depreciation and amortisation 4.13.87.9

add: Pro forma finance costs1.41.53.0

Pro forma Underlying EBITDA25.323.345.0

22
EBITDA per occupied bed, excluding decommissioned and development sites, is broadly in line with pcp.

Premium charges (care suite DMF and PAC revenue) increased 26% from the pcp

Care segment

1. Source –New Zealand Aged Care Association surveys

2. Maureen Plowman and Green Gables were decommissioned for redevelopment. Melrose and Trevellynboth have new care facilities under construction.

NZ$m1HY20181HY2017FY2017

Daily care fees75.974.3145.7

PAC revenue1.61.32.7

Care suite DMF1.81.43.0

Other revenue0.71.11.4

Total aged care operating revenue79.978.1152.8

Staff and resident expenses(55.6)(52.5)(105.8)

Occupancy and site overhead expenses(7.9)(7.2)(15.1)

Total aged care expenses(63.5)(59.7)(120.9)

Aged care pro forma Underlying EBITDA16.418.431.9

EBITDA per Care Bed / Suite (excl. decommissioned and

development sites)

$13,814$14,390$12,797

lOccupancy was ahead of the national

average of 86.9%

1

lCare suite DMF revenue increased 28.5% from

the pcp

lPremium charging (PAC and DMF) ahead of

the pcp. Average PAC of $13.49 vs $10.88 in

the pcp

lA number of sites have been decommissioned

or had major developments commence on

site

2

lThe year on year impact on earnings at these

sites is $0.8m

lOccupancy excluding the decommissioned

and development sites is 89.0%

Commentary

Occupancy rates versus national average

Premium care revenue

86.9%

85.2%

87.9%

86.7%

86.9%

90.9%

91.2%

92.0%

90.8%

88.6%

80.0%

84.0%

88.0%

92.0%

96.0%

1HY20141HY20151HY20161HY20171HY2018

National OccupancyOceania Occupancy

1.1

1.3

1.3

1.6

0.6

1.7

1.4

1.8

0.0

1.0

2.0

3.0

4.0

1HY20151HY20161HY20171HY2018

NZD $M's

PAC RevenueCare Suite DMF

CAGR of 26.0% over last 3 years

23
Pro Forma Underlying EBITDA was $3.8m ahead of the pcp

Village segment

NZ$m1HY20181HY2017FY2017

Villa and Apartment DMF7.86.613.3

Retirement village service fees2.72.75.3

Other revenue1.11.22.1

Total retirement village operating revenue11.510.520.6

Realised gains on resales6.76.412.7

Realised development margin4.10.95.2

Village site operating expenses(5.4)(5.0)(9.5)

Resident share of capital gains(0.5)(0.7)(2.2)

Total retirement village expenses(6.0)(5.7)(11.7)

Retirement village pro forma Underlying EBITDA16.312.126.8

Development Sales Volume and Margin

Resales Volume and Margin

75654871908369

10.3%

15.9%

18.3%

22.1%

24.7%

25.4%

28.4%

0%

5%

10%

15%

20%

25%

30%

0

20

40

60

80

100

1HY20121HY20131HY20141HY20151HY20161HY20171HY2018

18213054412523

9.9%

7.5%

12.6%

10.3%

18.4%

15.1%

36.4%

0%

5%

10%

15%

20%

25%

30%

35%

40%

0

10

20

30

40

50

60

1HY20121HY20131HY20141HY20151HY20161HY20171HY2018

lDeferred Management Fees continue to grow (18.2% c.fthe pcp) as new

developments are completed and resales occur at higher prices

lGains on resale were above the pcp despite lower volumes as margins

improved from 25.4% in the pcp to 28.4% in 1HY2018. This was driven by an 11.8%

increase in resale prices

lLower resales volumes in 1HY2018 due to low stock levels as at 31 May 2017

lDevelopment margin reflects the sales of the new Lady Allum apartments in

Milford, Auckland with prices in line with IPO Forecasts

Commentary

24
Resale prices and margins were above the pcp

Village segment –key indicators

Resales Prices

Closing Stock (inclstock under application) -Resales

33

31

37

17

22

36

15

9

20

0

5

10

15

20

25

30

35

40

Nov-16May-17Nov-17

VillasApartmentsCare Suites

lAverage resale margin increased from 25.4% in the pcp

to 28.4%, higher than any other comparable period

lThis was, in part, due to a material increase in the

average resale price for care suites (up 33% to $250k)

lResales prices achieved in 1HY2018 were, on average,

5.9% higher than the May 2017 CBRE valuation. The

chart depicts the variance to the prior annual valuation.

lAfter 12 months of relatively low stock levels, vacancies

arising in October and November increased stock by

29% compared to 30 November 2016. This will underpin

resales volumes through the second half of FY2018

lOf the 93 units available for resale at 30 Nov 17, 36

were under application

Resales Prices vs CBRE Valuation Assumption

246

250

263

299

318

372

376

252

313

314

326

331

386

435

132

163

173

156

158

188

250

0

100

200

300

400

500

1HY20121HY20131HY20141HY20151HY20161HY20171HY2018

NZD $000’s

VillaApartmentCare Suite

7.3%

12.0%

9.5%

16.5%

5.9%

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

12.0%

14.0%

16.0%

18.0%

1HY20162HY20161HY20172HY20171HY2018

25
The embedded value in Oceania’s portfolio has increased significantly over the last four years to $188.5m and will

underpin ongoing DMF cash flows and resale gains

Embedded value

1. Calculated as the current/estimated sale or resale price of all units/care suites as determined by CBRE. Note, the valuation of care suites held as PPE have been estimated using the May-17 valuation as

only Investment Properties was valued by CBRE in Nov-17. 2. The value of unsold stock represents the sales prices of units/care suites which are not under contract, as they either newly constructed or have

been bought-back from the previous outgoing residents.

Embedded value per unit

1

37.2

42.6

48.8

54.9

56.2

31.0

38.0

66.8

86.4

89.3

68.1

80.5

115.5

141.3

145.5

-

20

40

60

80

100

120

140

160

FY2014FY2015FY2016FY20171HY2018

DMFResale gains

Commentary

lEmbedded value in Oceania’s portfolio is $188.5m

lThis is an indicator of DMF and resale gains to be realised

in future periods and underpins our operating cash flow

forecasts

lEmbedded value per unit in 1HY2018 of c. $145,500

includes:

̶~$56,200 of DMF cash flows per unit to be realised; and

̶~$89,300 of resale gains per unit and suite

Summary of Embedded Value Calculation

NZ$m

FY2014FY2015FY2016FY20171HY2018

Estimated sale/resale price of all Units

1

322.4350.2402.7499.0595.8

less: Unsold stock

2

(32.4)(25.3)(14.3)(33.8)(125.1)

less: Resident liabilities (contractual)

(206.2)(223.3)(243.4)(282.1)(282.2)

equals: Embedded value

83.8101.6145.0183.1188.5

Embedded value per Unit (NZ$)

68,11980,531115,545141,298145,461

26
288

291

196

311

341

286

368

200

469

477

440

683

943

9885140

188

211

154

186

0

200

400

600

800

1,000

1HY20121HY20131HY20141HY20151HY20161HY20171HY2018

NZD $000’s

VillaApartmentCare Suite

Development margin of 36.4% was significantly above the pcp, with strong sales prices achieved at key developments.

We are bringing to market a high quality product that will generate considerable uplift in DMF in future periods

Developments –key indicators

Sales Prices

Development Volumes and Margins Gross Units Delivered

FY2014FY2015FY2016FY20171HY2018

Villas422411225

Apartments40140440

Total8238114625

lDevelopment margins have increased from 15.1% in the

pcp to 36.4% in 1HY2018 with prices in line with IPO

Forecasts

lAverage sales prices have increased from $233.0k (per

unit/care suite) in the pcp to $487.7k in 1HY2018

l25 units (excluding decommissions) delivered in 1HY2018

at Elmwood

l62 units and 30 care suites delivered at Meadowbank in

January. 10 villas completed at Stoke in December

lA further 113 units and 247 care suites currently under

construction

11

10

6

27

12

15

9

1

8

17

14

14

7

6

3

7

13

15

10

7

9.9%

7.5%

12.6%

10.3%

18.4%

15.1%

36.4%

0%

5%

10%

15%

20%

25%

30%

35%

40%

0

10

20

30

40

50

60

1HY20121HY20131HY20141HY20151HY20161HY20171HY2018

VillaApartmentCare SuiteDevelopment Margin

27
Total assets increased by $160.5m from 1HY2017 due to significant development capital expenditure during the 12 months

to November 2017 and revaluations reflecting improved trading performance and the completion of key developments

Balance sheet

●Our net adjusted value per share (CBRE plus WIP less

debt) was $1.01 per share as at 30 Nov 2017

●This represents the value of existing sites and the WIP at

development sites but excludesthe present value of net

development cashflows and earnings at both current

and future developments (including The Sands and

Meadowbank Stage 4 which are under construction)

NZ$m1HY20181HY2017FY2017

Assets

Cash and trade receivables21.413.822.2

Property, plant and equipment279.2244.5268.0

Investment properties681.3562.9611.0

Intangible assets17.317.317.1

Total assets999.1838.6918.2

Liabilities

Trade, other payables and provisions28.123.627.8

Deferred management fees 18.818.919.5

Refundable occupation right agreements290.8266.7282.9

Borrowings123.8275.895.2

Deferred tax liability26.729.724.8

Total liabilities488.2614.6450.3

Equity

Contributed Equity579.5372.6579.5

Retained Deficit(153.4)(218.9)(196.0)

Reserves84.870.384.4

Total equity510.9224.0468.0

Net tangible assets493.6206.6450.9

NZ$m1HY2018FY2017

PP&E (inc WIP)279.2268.0

IP (incl WIP)681.3611.0

Sub Total960.4879.0

less ORA Gross Up(309.6)(302.4)

add: Adj for CBRE –Chattels9.57.9

add: Adj for CBRE –Care Goodwill61.059.0

add: Other10.94.5

CBRE plus WIP732.1647.9

less: Net Debt(117.6)(84.4)

Net Adjusted Value614.5563.5

Shares on Issue610.3610.3

Net Adjusted Value per Share1.010.92

28
Significant uplifts in IP through development capital expenditure and revaluations

Balance sheet drivers

1. The CBRE valuation was dated 31 October 2017. Management performed a roll forward for settlements in the month of November.

Investment Property

CBRE Valuation Assumptions -IP

lA desktop portfolio valuation was completed by CBRE to

determine the fair value of Investment Property as at

November 2017

1

lPPE (Care Segment) and development land were held at the

May-17 valuation plus additions

lMaterial increase in the average incoming villa and

apartments price due to the inclusion of Meadowbank and

Elmwood developments

NZD $000’s

Driver1HY2018FY2017

PPGR –Long Term (low-high)2.50%3.50%2.50%3.50%

PPGR –Short Term (low-high)0.00%3.00%0.0%3.00%

Discount Rates (low-high)14.00%22.00%14.00%22.00%

Average Incoming Price -Villas$378,013$359,350

Average Incoming Price –Apartments$653,011$570,291

611,016

681,261

186

11,748

9,761

5,185

35,723

376

7,266

550,000

570,000

590,000

610,000

630,000

650,000

670,000

690,000

710,000

May-17Site remediation

work

MeadowbankElmwoodLady AllumCapexTransfer from

PP&E

Existing village

reval

Nov-17

29
We have significantly increased our growth capital expenditure following the IPO

Development capital expenditure

Growth Capital Expenditure (IP and PPE)

Our growth capital expenditure will create incremental development cashflows as well as increased care earnings

and deferred management fees

-

5.00

10.00

15.00

20.00

25.00

30.00

35.00

40.00

45.00

1HY20152HY20151HY20162HY20161HY20172HY20171HY2018

NZD $M's

Growth Capex

Melrose

Tauranga

30
Statement of cash flows

Operating cash flows, ahead of the pcp, due to the reduced gearing of the business

Cash flow

lGovernment funding of care fees

(c.80% of aged care revenue, paid

fortnightly) underpin the generation

of cash flows from our aged care

business

lIn addition, our mature and growing

retirement village portfolio provides

recurring DMF revenue and resale

gains, which support cash

generation

lOur Embedded Value of $188.5m

underpins the next 5-7 years of

retirement village cash flows

lNote –Reported Operating

Cashflow includes $3.8m of ORA

buy backs for new developments

and $2.7m for deposits for land

acquisitions.

Commentary

NZD $m’s1HY20181HY2017FY2017

Receipts from customers78.581.5159.3

Payments to suppliers and employees(76.1)(74.6)(141.1)

Receipts from new Occupational Rights Agreements34.431.368.8

Payments for outgoing Occupational Rights Agreements(18.6)(16.7)(30.9)

Interest received0.10.10.1

Interest paid(1.3)(8.8)(17.3)

Tax paid0.00.00.0

Net cash inflow from operating activities17.112.838.9

Proceeds from sale of property, plant and equipment0.20.00.0

Proceeds from sale of business0.00.00.0

Payments for PPE and intangible assets(14.3)(8.7)(33.5)

Payments for investment property and investment property under

development

(34.6)(21.0)(47.6)

Net cash outflow from investing activities(48.8)(29.7)(81.1)

Proceeds from borrowings44.831.6145.0

Repayment of borrowings(17.7)(16.7)(285.4)

Transaction costs0.00.0(10.7)

Proceeds from issue of shares0.00.0200.0

Dividend paid0.00.00.0

Net cash inflow from financing activities 27.115.048.9

Net increase in cash and cash equivalents(4.6)(2.0)6.8

Cash and cash equivalents at beginning of the period10.94.14.1

Cash and cash equivalents at end of the period6.22.110.9

1. See Appendices for a reconciliation of Operating Cash flow to the adjusted operating cash flow metric previously presented

31
lA maiden dividend of 2.1 cents per share (not imputed) has been declared

lThis is in line with the IPO forecast

lRecord date of 13 February 2018. Payment date of 20 February 2018

lSubject to a range of factors, including market conditions and future funding requirements, our dividend policy is to

target an annual dividend of between 50-60% of Underlying NPAT

lThe IPO forecast dividend declared of $28.3m for FY2018 is based on approximately 55% of FY2018F Underlying NPAT

and represents a gross yield of 4.61% based on a 30 day VWAP to 16 January of $1.0 per share

An interim dividend of 2.1 cents per share has been declared

Dividend

32
1. Note-including the settlement of Waimarie Street and land at Eden this becomes 22.0% (using the November 2017 equity figure)

Net Debt

Gearing of 18.7% as at 30 November 2017 and headroom under our debt facilities provides the flexibility to accelerate our

existing brownfield development pipeline and/or undertake further brownfield and greenfield acquisitions

Capital structure

Credit metrics

Debt FacilitiesFacility limit

Drawn Amount

(30/11/17)

General / corporate

$60m$20.0m

Cash

n/a($6.2m)

Finance leases

n/a$5.8m

Development facility

$175m$98.6m

Total net debt

$235m$118.1m

Periodending1HY2018FY2017

Net debt

$118.1m

$84.4m

Net debt / (net debt + equity)18.70%

1

15.30%

Loan to value ratio16.76%15.79%

3333
01Portfolio Summary

02Development Pipeline

03Reconciliation of Portfolio Movements

04Summary of Unit Sales

05Capital Expenditure

06Adjusted Operating Cash Flow

07Resales Cash Flow Reconciliation

08Definition of Underlying NPAT

09Pro Forma Adjustments

10Glossary

11Disclaimer

Appendices

Portfolio summary (30 Nov 2017)
FacilityRegionCategoryCare BedsCare SuitesVillage Units

Totara Park VillageRodneyVillage--30

Greenvalley Rest HomeNorth ShoreCare Beds50--

Lady Allum Lifestyle Care & VillageNorth ShoreCare Beds, Care Suites, Village12815129

Te Mana Rest HomeNorth ShoreCare Beds46--

Amberwood Rest HomeWaitakereCare Beds67--

Eden Lifestyle Care & VillageAucklandCare Suites, Village-6740

Everil Orr Specialist Senior Care CentreAucklandCare Beds67--

Meadowbank Lifestyle Care & VillageAucklandVillage--56

Wesley Specialist Senior Care CentreAucklandCare Beds71--

Elmwood Lifestyle Care and VillageManukauCare Beds, Care Suites, Village11148129

St Johns VillageManukauVillage--18

Takanini Specialist Senior Care CentreManukauCare Beds91--

Franklin Rest HomeFranklinCare Beds44--

Trevellyn Lifestyle Care & VillageHamiltonCare Beds, Village106-43

Raeburn Rest HomeCambridgeCare Beds54--

Whitianga Rest HomeWhitiangaCare Beds53--

Elmswood Rest HomeTaurangaCare Beds38--

Melrose Lifestyle Care & VillageTaurangaCare Beds, Village80-60

Ohinemuri Rest HomePaeroaCare Beds, Village68-6

Victoria PlaceTokoroaCare Beds51--

St Johns Wood Rest Home & VillageTaupoCare Beds, Care Suites, Village40633

Wharerangi Rest HomeTaupoCare Beds, Village47-17

Dunblane Rest Home & VillageGisborneCare Beds, Village75-13

Duart Rest HomeHastingsCare Beds66--

Eversley Lifestyle Care & VillageHastingsCare Beds, Village50-6

Gracelands Lifestyle Care & VillageHastingsCare Beds, Village92-69

Atawhai Lifestyle Care & VillageNapierCare Beds, Care Suites, Village681446

Woburn ResthomeHawke's BayCare Beds33--

Chiswick Park Rest HomePalmerston NorthCare Beds50--

Palmerston Manor ResthomePalmerston NorthCare Beds48--

Eldon Specialist Senior Care CentreParaparaumuCare Beds128--

Elderslea Specialist Senior Care CentreUpper HuttCare Beds124--

Heretaunga Resthome & VillageUpper HuttCare Beds, Care Suites, Village3020-

Hutt Gables Retirement VillageUpper HuttVillage--46

Marina Cove VillagePictonVillage--22

Green Gables Resthome & VillageNelsonVillage--12

Otumarama ResthomeNelsonCare Beds43--

Stoke Retirement VillageNelsonVillage--104

Whareama Specialist Senior Care CentreNelsonCare Beds77--

Redwood Lifestyle Care & VillageBlenheimCare Beds, Care Suites, Village651346

Woodlands Resthome & VillageTasmanCare Beds, Village56530

Holmwood Rest HomeChristchurchCare Beds56--

Middlepark Rest Home & VillageChristchurchCare Beds, Care Suites4912-

Palm Grove Lifestyle Care & VillageChristchurchCare Beds, Care Suites, Village424232

Resthaven Rest HomeChristchurchCare Beds49--

The Oaks Lifestyle Care & VillageChristchurchCare Beds, Care Suites, Village693632

Windermere Lifestyle Care & VillageChristchurchVillage--17

Addington Lifestyle CareChristchurchCare Beds, Care Suites8710-

Total2,5692881,036

North Island

South Island

35
Development pipeline

SiteStageStatusGross UnitsNet UnitsNotes:

Meadowbank

Stage 3Under Construction9292Construction complete in January 2018

Stage 4Under Construction8181

Construction began in Oct-17. Expected

completion May 2019

Stage 5Consented2626

Stage 6Planned4040

The Sands (formerly Maureen Plowman)

Under Construction108108Expected completion May 2019

Stoke

Under Construction1010Construction complete in January 2018

Melrose

Stage 1Under Construction8181

Construction began July-

17. Expected

completion 2Q2018

Stage 2-5Consented216107

Trevellyn

Stage 1Under Construction9087Construction began January 18

Stage 2-3Consented13327

Green Gables

Consented8888

Windermere

Stage 1Consented7575

Stage 2-3Consented5336

Wharerangi

Consented4(2)

Eden

Planned3030

Waimarie Street

Planned6666

Other

Hawkes BayPlanned165159

ChristchurchPlanned224175

NelsonPlanned11522

VariousPlanned8585

Total Consented/under construction1,057816

Total Pipeline1,7821,393

36
Reconciliation of portfolio movements

Movements in capacity and pipeline since May-17

May-17

Changes in

existing

capacity

Conversion of

beds to care

suites

Conversion of

units to care

suites

New units

delivered

Changes in

pipeline –gross

units added

Changes in

pipeline -

decommissions

Nov-17

Existing

Care beds2,580(2)(9)2,569

Care Suites242739288

Units1,054(4)(39)251,036

Pipeline

Care beds(354)43(311)

Care Suites63530665

Units1,001(25)69(6)1,039

Total5,158(6)(2)0099375,286

Movements in gross pipeline since May-17 (from above)

37
Summary of unit sales

1HY20121HY20131HY20141HY20151HY20161HY20171HY2018

Care Suite

1013428263225

Apartment

23171416282012

Villa

42353027363132

Total

75654871908369

Resales Margin

10.27%15.90%18.26%22.11%24.69%25.44%28.36%

1HY20121HY20131HY20141HY20151HY20161HY20171HY2018

Care Suite6371315107

Apartment1817141407

Villa111062712159

Total18213054412523

Development Margin9.9%7.5%12.6%10.3%18.4%15.1%36.4%

New Sales

Resales

1HY20121HY20131HY20141HY20151HY20161HY20171HY2018

Care Suite

11,85013,73117,50020,56322,71229,81856,480

Apartment

25,52219,10532,92975,99469,05099,34596,542

Villa

25,89959,11161,36378,352100,190112,506127,926

Total

23,91039,57249,41555,03068,11977,45596,582

Average resale gain per unit/care suite

38
We increased our development capital expenditure significantly during 1HY2018

Capital expenditure

lDuring 1HY2018 we completed the conversion of 7 care beds

and 39 service apartments to care suites as well as continued

the remediation of Heretaunga. This is due to complete in

2HY2018

lCost of remediating the balance of sites identified in our IPO

due diligence revised downwards by $2.7m following more

detailed investigation of building issues. These exercise should

be complete by FY2018

NZ$m1HY20181HY2017FY2017

Acquisitions

0.03.023.0

Development capital expenditure

41.522.848.8

Remediation expenditure

2.00.31.8

Care refurbishment

0.00.61.1

Care conversion and premium room upgrades

0.90.40.7

Maintenance capital expenditure –aged care

1.41.12.7

Maintenance capital expenditure –retirement

village

2.01.22.2

Maintenance capital expenditure –IT and other

0.50.30.7

Total conversions and maintenance

4.83.67.4

Adjustment for accruals

0.6(0.0)0.0

Total Capex per statutory cashflow statement

48.929.781.1

Assets under finance leases

0.31.43.0

Total capital expenditure (including assets under

finance leases)

49.231.184.1

39
We generated $13.3m of adjusted operating cash flow (excludes new sales proceeds, includes net

development cashflow) in 1HY2018

Adjusted operating cash flow

Adjusted operating cash flow

1.The deposits paid for the land acquisitions at View Rd and Waimarie St are included in payments to suppliers and employeesinthe cashflow statement in the interim financial statements

2. Net development cashflow is the difference between the sales prices and all construction costs and finance costs (including communal areas). It excludes brownfields land. It captures the incremental

cashflow generated from a development on a per unit basis once sold

NZD $m’s1HY20181HY2017FY2017

Operating Cash Flow

17.112.838.9

less: New Sales Proceeds

(11.2)(5.8)(22.8)

add: Development Buybacks

3.81.03.2

add: Land Acquisition Deposits

1

2.70.00.0

add: Net Development Cashflow

2

4.81.46.7

Sub Total:

17.29.426.0

less: maintenance capex

(3.9)(2.5)(5.6)

Adjusted Operating Cash Flow13.36.820.4

lOur steady operating cashflows fund our dividend

payments

lThese cashflows are supported by the government

funding of 80% of our care revenues

lAs our development pipeline is predominantly

brownfields we generate incremental net

development cashflows (including recovering the

costs of community amenities etc). In 1HY2018 our

net development cashflow was $4.8m compared to

our development margin of $4.1m in our underlying

profit.

lForecast dividend payment of $28.3m for FY2018

represents a gross yield of 4.61% based on a 30 day

VWAP to 16 January of $1.0 per share

12.8

17.1

6.8

13.3

0.0

5.0

10.0

15.0

20.0

1HY20171HY2018

NZD $M's

Operating cash flowAdjusted cash flow

40
Reconciliation of resales cash flow

1. The net buybacks comprised $2.8m at development sites and $1.0m at Heretaunga to facilitate the remediation work.

NZD $m’s1HY20181HY2017FY2017

Receipts from New ORAs34.431.368.8

less: Payments for Outgoing ORAs(18.6)(16.7)(30.9)

less: Cash Inflow From New Sales(11.2)(5.8)(22.8)

Net Resales Cash flow4.68.815.1

Made up of :

Resale Gains6.76.412.7

DMF Realised on Resales2.94.16.8

less: Net Buybacks

1

(3.8)(1.0)(3.2)

less: Resident Share of Capital Gains (0.8)(0.6)(1.1)

less: Other Cash amounts paid/received from resales(0.3)(0.1)(0.1)

Net Cash flows from Resales 4.68.815.1

Reconciliation of resales cash flow

41
Underlying Profit (or Underlying NPAT)

Underlying Profit is a non-GAAP measure used by the Group to monitor financial performance

and is consideration in determining dividend distributions. It is reported in the operating segment

note of the audited consolidated financial statements. Underlying measures require a

methodology and a number of estimations to be approved by Directors in their preparation. Both

the methodology and the estimations may differ among companies in the retirement village

sector that report underlying financial measures. Underlying profit is a measure of financial

performance and does not represent business cash flow generated during the period.

Oceania calculates Underlying Profit by making the following adjustments to Reported Net Profit

after Tax:

•Removing the change in fair value of investment properties and the impairment of property,

plant and equipment (from the Statement of Comprehensive Income);

•Removing any impairment of goodwill;

•Removing any loss on disposal of chattels from the decommissioning of development sites;

•Adding back the Directors’ estimate of realised gains on occupation right agreement units

and care suites;

•Adding back the Directors’ estimate of realised development margin on the cash settlement

of the first sale of new ORA units or care suites following the development, or conversion of an

existing care bed to a care site or conversion of a rental unit to an ORA Unit; and

•Adding back the deferred taxation component of taxation expense so that only current tax

expense is reflected.

Resale Gain

The Directors’ estimate of realised gains on resales of ORA is calculated as the net cash flow

received by the Group on the cash settlement of the resale of pre-existing ORAs (i.e. the

difference between the ORA licence payment received from the incoming resident and the ORA

licence payment previously received from the outgoing resident).

Development Margin

The Directors’ estimate of realised development margin is calculated as the cash received on

settlement of the first sale of new ORA Units and care suites less the development costs

associated with developing the ORA Units and care suites. The development costs include:

•Construction costs directly attributable to the relevant project, including any required

infrastructure (e.g. roading) and amenities related to the units (e.g. landscaping) as well as

any demolition and site preparation costs associated with the project. The costs are

apportioned between the ORA units and care suites, in aggregate, using estimates provided

by the project quantity surveyor. The construction costs for the individual ORA units or care

suites sold are determined on a pro-rated basis using gross floor areas of the ORA units and

care suites;

•An apportionment of land valued based on the gross floor area of the ORA units and care

suites developed. The value for Brownfield development land is the estimated fair value of

land at the time a change of use occurred (from operating as a care facility or retirement

village to a development site), as assessed by an external independent valuer. Greenfield

development land is valued at historical cost; and

•Capitalised interest costs to the date of project completion apportioned using the gross floor

area of ORA units and care suites developed.

Development costs do not include:

•Construction, land (apportioned on a gross floor area basis) and interest costs associated with

common areas and amenities or any operational or administrative areas.

The Directors’ estimate of development margin for conversions of care beds to care suites and

rental units to ORAs is calculated based on the difference between the ORA licence payment

received on the settlement of sales of newly converted ORA units and care suites and the

associated conversion costs. Conversion costs comprise:

•In the case of conversion of care beds to care suites, the actual refurbishment costs incurred;

and

•In the case of conversions of rental units to ORA units, the actual refurbishment costs incurred

and the fair value of the rental unit prior to conversion.

Underlying NPAT

42
Transaction and offer costs

Total transaction and offer costs of $11.9m were incurred relating to joint lead manager fees, due diligence expenses, travelexpenses, advertising, printing costs, and other costs

associated with the IPO. Of these $4.4m million were expensed by Oceania in FY2017. A pro forma adjustment has been made to remove these one-off expenses to illustrate

Oceania’s financial performance in FY2017 and prior periods on a consistent basis.

Listed company costs

Oceania has incurred additional costs associated with the listed environment including Directors’ fees, additional audit and taxcosts, listing fees, share registry fees, investor relations

costs, company secretarial costs, and annual general meeting costs. To ensure that the historical financial information is presented on a comparable basis, a pro forma adjustment

has been made to include estimated listed company costs representing Oceania as if it was a listed company in each of those periods.

Listed company capital structure

The proceeds of the IPO were used to substantially repay a portion of Oceania’s prior debt facilities. This means that Oceania’s reported NPAT and Underlying NPAT measures for

FY2017 do not reflect Oceania’s financial performance on a normalised, annual basis under its current capital structure because the structural reduction in debt (and interest

expense) that arose from the IPO was not in effect for all 12 months of FY2017. Accordingly, a pro forma adjustment has been made to present the interest expense and Underlying

NPAT that would have arisen had a listed capital structure been in place from the start of the financial year. This enables the financial performance for FY2017 to be more effectively

assessed and compared to FY2018 and future periods.

This pro forma adjustment includes an adjustment for the write-off of prepaid facility fees on Oceania’s historical debt facility. The prepaid facility fees relating to the historical debt

facility were required to be written off in accordance with accounting standards as the IPO occurred prior to the maturity date of the historical debt facility.

This pro forma adjustment includes an adjustment for the acquisition of the freehold land and building at the Elderslea aged care facility which has previously been recognised as a

finance lease in Oceania’s historical financial statements.

In addition, a shareholder loan of $13.4 million was advanced to Oceania from its immediate holding company in June 2016 to facilitate the construction of the Stage 3 development

at Meadowbank. The shareholder loan was settled by way of a subscription for equity in Oceania in January 2017. A pro forma adjustment has been made to remove the interest

charges incurred on the shareholder loan in FY2017.

Pro forma adjustments

43
lCare Suite: A room or studio certified for the provision of care by the Ministry of Health which has been licensed under an ORA

lDMF: Deferred management fees, charged under an ORA, which accrue monthly to a specified maximum and are deducted from the refund

paid to the departing resident upon resale of the unit or care suite

lIP: Investment Property

lIPO Forecasts: Prospective Financial Information contained in the Product Disclosure Statement and Supplementary Financial Information

dated 31 March 2017

lMoH: Ministry of Health

lORA: An occupation right agreement that confers on a resident the right to occupancy a unit or care suite subject to certain terms and

conditions set out in the agreement

lPAC: Premium accommodation charge on a care bed for accommodation provided above the mandated minimum

lPPE: Property, Plant and Equipment

lUnit: Includes independent villas and apartments

lWIP: Work in progress

Glossary

44
This presentation has been prepared solely by Oceania Healthcare Limited ("Oceania"). You must read this disclaimer before making any use of

this presentation and the accompanying material or any information contained in it ("Document").

The presentation includes non-GAAP financial measures for development sales, resales and occupancy which assist the reader with

understanding the volumes of units settled during the period and the impact that development sales and resales during the periodhad on

occupancy as at the end of the period.

The addition of totals and subtotal within tables and percentage movements may differ due to rounding.

The information set out in this Document is an overview and does not contain all information necessary to make an investment decision. It is

intended to constitute a summary of certain information relating to the performance of Oceania for the period ending 30 Nov 2017. Please refer to

the Financial Statements for the period ended 30 Nov 2017 that have been released along with this presentation.

The information in this presentation does not purport to be a complete description of Oceania. In making investment decisions, investors must rely

on their own examination of Oceania, including the merits and risks involved. Investors should consult their own legal, tax and/or financial advisors

in connection with any acquisition of financial products.

The information contained in this presentation has been prepared in good faith by Oceania. No representation or warranty, expressed or implied,

is made to the accuracy, adequacy or reliability of any statements, estimates or opinions or other information contained in thispresentation, any

of which may change without notice. To the maximum extent permitted by law, Oceania, its directors, officers, employees and agents disclaim all

liability and responsibility (including without limitation any liability arising from fault or negligence on the part of Oceania, its directors, officers,

employees and agents) for any direct or indirect loss or damage which may be suffered by any person through the use of or reliance on anything

contained in, or omitted from, this presentation.

This presentation is not a product disclosure statement, prospectus, investment statement or disclosure document, or an offerofshares for

subscription, or sale, in any jurisdiction.

Receipt of this Document and/or attendance at this presentation constitutes acceptance of the terms set out above in this disclaimer.

Important notice and disclaimer

---

Oceania Healthcare Limited
Results for announcement to the market


Reporting Period 6 months to 30 November 2017

Previous Reporting

Period

6 months to 30 November 2016


Amount (000s) Percentage change

Revenue from ordinary

activities

$NZ 92,123 3.25%

Change in fair value of

investment properties

$NZ 34,147 4.60%

Total Revenue $NZ 126,270 3.61%

Reported Net Profit

(loss) from ordinary

activities after tax

attributable to security

holder

$NZ 42,521 93.52%

Reported Net Profit

(loss) attributable to

security holders

$NZ 42,521 93.52%


Final Dividend Amount per security Imputed amount per

security

$NZ 0.0210 $NZ 0.0000


Record Date 13 February 2018

Dividend Payment Date 20 February 2018


30 November 2017 30 November 2016

Net tangible assets per

security

$NZ0.81 $NZ0.61


Comments: A brief Please refer to other attached documents (unaudited

consolidated financial statements and interim report,

media release and results presentation).


m


The fi

---

APPENDIX 7 – NZSX Listing Rules
Number of pages including this one

(Please provide any other relevant

NZSX Listing Rule 7.12.2. For rights, NZSX Listing Rules 7.10.9 and 7.10.10. details on additional pages)

For change to allotment, NZSX Listing Rule 7.12.1, a separate advice is required.

Full name

of Issuer

Name of officer authorised to

Authority for event,

make this notice

e.g. Directors' resolution

Contact phone

Contact fax

numbernumber

Date

Nature of event

BonusIf ticked,

Rights Issue

Tick as appropriate

Issue

state whether:Taxable

/ Non TaxableConversionInterestRenouncable

Rights IssueCapitalCallDividend

If ticked, stateFull

non-renouncable

change

x

whether:

Interim

x

YearSpecialDRP Applies

EXISTING securities affected by this

If more than one security is affected by the event, use a separate form.

Description of theISIN

class of securities

If unknown, contact NZX

Details of securities issued pursuant to this eventIf more than one class of security is to be issued, use a separate form for each class.

Description of theISIN

class of securities

If unknown, contact NZX

Number of Securities toMinimum

Ratio, e.g

be issued following eventEntitlement

1 for 2 for

Conversion, Maturity, Call

Treatment of Fractions

Payable or Exercise Date

Tick if

provide an

pari passu

ORexplanation

Strike price per security for any issue in lieu or date

of the

Strike Price available.

ranking

Monies Associated with Event

Dividend payable, Call payable, Exercise price, Conversion price, Redemption price, Application money.

Source of

Amount per securityPayment

(does not include any excluded income)

Excluded income per security

(only applicable to listed PIEs)

SupplementaryAmount per security

Currencydividendin dollars and cents

details -

NZSX Listing Rule 7.12.7

Total monies

TaxationAmount per Security in Dollars and cents to six decimal places

In the case of a taxable bonusResident

Imputation Credits

issue state strike priceWithholding Tax(Give details)

Foreign

FDP Credits

Withholding Tax(Give details)

Timing

(Refer Appendix 8 in the NZSX Listing Rules)

Record Date 5pmApplication Date

For calculation of entitlements -Also, Call Payable, Dividend /

Interest Payable, Exercise Date,

Conversion Date.

Notice DateAllotment Date

Entitlement letters, call notices,For the issue of new securities.

conversion notices mailedMust be within 5 business days

of application closing date.

OFFICE USE ONLY

Ex Date:

Commence Quoting Rights:Security Code:

Cease Quoting Rights 5pm:

Commence Quoting New Securities:Security Code:

Cease Quoting Old Security 5pm:

EMAIL: announce@nzx.com

Notice of event affecting securities

Oceania Healthcare Limited (OCA)

Anna ThorburnDirectors Resolution

+ 64 9 213 102225012018

Ordinary SharesNZOCA000250

NA

In dollars and cents

Interim Dividend ex Retained Earnings

$0.0210

Enter N/A if not

applicable

NA$0.006930NA

NANA

New Zealand DollarsNA

$12,815,345

Date Payable

NA

13 February, 201820 February, 2018

NANA

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.